Key facts
- This page summarizes Edward M. Brown's Form 4 filing for Cardiovascular Systems Inc.
- 1 reported transaction and 2 derivative rows are listed below.
- Accepted by SEC: 11 Aug 2021, 19:18.
Edward M. Brown - 09 Aug 2021 Form 4 Insider Report for Cardiovascular Systems Inc
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 09 Aug 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Andrew Nick as Attorney-in-Fact for Edward M. Brown pursuant to Power of Attorney filed herewith.
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Edward M. Brown filed Form 4 for Cardiovascular Systems Inc on 11 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CSII
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 107,421
- Date
- 09 Aug 2021
- Ownership
- By Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CSII
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +3,814
- Change %
- Price
- $0.000000
- Shares after
- 3,814
- Date
- 09 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,814
- Exercise price
- Footnotes
- F2
CSII
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 90,841
- Date
- 09 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 90,841
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
Footnote F2
Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 954 shares on each of September 30, 2021 and December 31, 2021 and as to 953 shares on each of March 31, 2022 and June 30, 2022.